B Positive – all you wanted to know about - ASHM

REFERENCES
1. bosch fX, ribes J, borras J. epidemiology
of primary liver cancer. semin Liver dis
1999;19(3):271-85.
2. amin J, dore GJ, o’connell d L, bartlett M,
tracey e, Kaldor JM, et al. cancer incidence in
people with hepatitis b or c infection: a large
community-based linkage study. J Hepatol
2006;45(2):197-203.
3. chu cM. natural history of chronic hepatitis b
virus infection in adults with emphasis on the
occurrence of cirrhosis and hepatocellular
carcinoma. J Gastroenterol Hepatol
2000;15(suppl):e25-30.
4. Parkin dM, bray f, ferlay J, Pisani P. Global
cancer statistics, 2002. ca cancer J clin
2005;55(2):74-108.
5. Liu J, fan d. Hepatitis b in china. Lancet
2007;369(9573):1582-3.
6. coates M, tracey e. cancer in new south
Wales: incidence and mortality 1997. nsW
Public Health bull 2001;12(2):40-2.
7. tracey e, chen s, baker d, bishop J, Jelfs P.
cancer in new south Wales: incidence and
Mortality 2004. sydney: cancer institute
nsW, 2006.
8. seeff Lb, Hoofnagle JH. epidemiology of
hepatocellular carcinoma in areas of low
hepatitis b and hepatitis c endemicity.
oncogene 2006;25(27):3771-7.
9. Visser o, van Leeuwen fe. cancer risk in
first generation migrants in north-Holland/
flevoland, the netherlands, 1995-2004. eur J
cancer 2007;43(5):901-8.
10. schiff er. Prevention of mortality from
hepatitis b and hepatitis c. Lancet
2006;368(9539):896-7.
11. de Masi s, tosti Me, Mele a. screening for
hepatocellular carcinoma. dig Liver dis
2005;37(4):260-8.
12. bolondi L. screening for hepatocellular
carcinoma in cirrhosis. J Hepatol
2003;39(6):1076-84.
13. chen ds, sung JL, sheu Jc, Lai My,
How sW, Hsu Hc, et al. serum alphafetoprotein
in the early stage of human
hepatocellular carcinoma. Gastroenterology
1984;86(6):1404-9.
14. bruix J, Hessheimer aJ, forner a, boix L,
Vilana r, Llovet JM. new aspects of diagnosis
and therapy of hepatocellular carcinoma.
oncogene 2006;25(27):3848-56.
15. sherman M. Hepatocellular carcinoma:
epidemiology, risk factors, and screening.
semin Liver dis 2005;25(2):143-54.
16. Zhang bH, yang bH, tang Zy. randomized
controlled trial of screening for hepatocellular
carcinoma. J cancer res clin oncol
2004;130(7):417-22.
17. Plesch fn, Kubicka s, Manns MP. Prevention
of hepatocellular carcinoma in chronic liver
disease: molecular markers and clinical
implications. dig dis 2001;19(4):338-44.
18. rugge Jb, Lochner J, Judkins d. What is
the best surveillance for hepatocellular
carcinoma in chronic carriers of hepatitis b?
J fam Pract 2006;55(2):155-6;
19. tanaka H, nouso K, Kobashi H, Kobayashi y,
nakamura s, Miyake y, et al. surveillance of
hepatocellular carcinoma in patients with
hepatitis c virus infection may improve
patient survival. Liver int 2006;26(5):543-51.
20. chalasani n, said a, ness r, Hoen H, Lumeng
L. screening for hepatocellular carcinoma
in patients with cirrhosis in the united
states: results of a national survey. am J
Gastroenterol 1999;94(8):2224-9.
21. Mann cd, neal cP, Garcea G, Manson
MM, dennison ar, berry dP. Prognostic
molecular markers in hepatocellular
carcinoma: a systematic review. eur J cancer
2007;43(6):979-92.
22. arii s, tanaka J, yamazoe y, Minematsu s,
Morino t, fujita K, et al. Predictive factors
for intrahepatic recurrence of hepatocellular
carcinoma after partial hepatectomy. cancer
1992;69(4):913-9.
23. nagao t, inoue s, Goto s, Mizuta t, omori
y, Kawano n, et al. Hepatic resection for
hepatocellular carcinoma. clinical features
and long-term prognosis. ann surg
1987;205(1):33-40.
24. Pompili M, rapaccini GL, covino M, Pignataro
G, caturelli e, siena da, et al. Prognostic factors
for survival in patients with compensated
cirrhosis and small hepatocellular carcinoma
after percutaneous ethanol injection therapy.
cancer 2001;92(1):126-35.
25. nagasue n, Kohno H, chang yc, taniura H,
yamanoi a, uchida M, et al. Liver resection
for hepatocellular carcinoma. results of 229
consecutive patients during 11 years. ann
surg 1993;217(4):375-84.
26. Qin LX, tang Zy. the prognostic significance
of clinical and pathological features
in hepatocellular carcinoma. World J
Gastroenterol 2002;8(2):193-9.
b Positive – all you wanted to know about hepatitis b: a guide for primary care providers 73